Professional Documents
Culture Documents
Preface
Public Comment
Comments and suggestions may be submitted at any time for Agency consideration to Dockets
Management Branch, Division of Management Systems and Policy, Office of Human Resources and
Management Services, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305),
Rockville, MD, 20852. When submitting comments, please refer to the exact title of this guidance
document. Comments may not be acted upon by the Agency until the document is next revised or
updated.
For questions regarding the use or interpretation of this guidance which involve the Center for Devices
and Radiological Health (CDRH), contact John F. Murray at (301) 594-4659 or email
jfm@cdrh.fda.gov
For questions regarding the use or interpretation of this guidance which involve the Center for Biologics
Evaluation and Research (CBER) contact Jerome Davis at (301) 827-6220 or email
davis@cber.fda.gov.
Additional Copies
CDRH
Additional copies are available from the Internet at: www.fda.gov/MedicalDevices/
DeviceRegulationandGuidance/GuidanceDocuments/UCM085281.htm.
You may also send an e-mail request to dsmica@fda.hhs.gov to receive an electronic copy of the
guidance or send a fax request to 301-847-8149 to receive a hard copy. Please use the document
number (938) to identify the guidance you are requesting.
CBER
Additional copies are available from the Internet at: http://www.fda.gov/cber/guidelines.htm, by
writing to CBER, Office of Communication, Training, and Manufacturers' Assistance (HFM-
40), 1401 Rockville Pike, Rockville, Maryland 20852-1448, or by telephone request at 1-
800-835-5709 or 301-827-1800.
Page ii
Guidance for Industry and FDA Staff General Principles of Software Validation
Table of Contents
2.1. Applicability........................................................................................................................ 2
2.2. Audience ............................................................................................................................. 2
2.3. THE LEAST BURDENSOME APPROACH................................................................... 2
2.4. Regulatory Requirements for Software Validation.......................................................... 3
2.4. Quality System Regulation vs Pre-Market Submissions ................................................. 4
Page iii